Lantheus Holdings, Inc.
Nasdaq · Healthcare · In Vitro & In Vivo Diagnostic Substances · Bedford, MA
LNTH chart
What traders are saying about $LNTH
Latest postsLantheus Holdings, Inc. news
- ETFs Are Net Sellers of Lantheus (LNTH) on Oct. 22
Yahoo Finance ·
- Lantheus Holdings, Inc. Estimates – NASDAQ:LNTH
TradingView ·
- FTC Second Requests Extend HSR Waiting Period for Curium-Lantheus Deal
TOKENPOST ·
- Lantheus Holdings (LNTH) Holds the $100 Line as Shares Edge 0.08% Lower - Swing Trade Setups
www.dars.gov.et ·
- FTC Wants More Info On Curium's $8B Deal For Lantheus
Law360 ·
- Form 8K Lantheus Holdings Inc For: 22 October By Investing.com
Investing.com Nigeria ·
- Lantheus (LNTH) Faces FTC Second Request in $8B Curium Acquisiti
GuruFocus ·
- Lantheus receives FTC second request on Curium deal
Seeking Alpha ·
- Lantheus Holdings, Inc. (LNTH) Stock Forecasts
Yahoo Finance ·
- ETFs Are Selling Lantheus (LNTH) on Oct. 19
Yahoo Finance ·
- GE HealthCare Wins Approval for MINItrace Magni Cyclotron in Europe
Yahoo Finance ·
- 1 Russell 2000 Stock with Exciting Potential and 2 That Underwhelm
Yahoo Finance ·
Lantheus Holdings, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.54B | $1.53B | $1.30B | $935.1M |
| Net income | $233.6M | $312.4M | $326.7M | $28.1M |
| Diluted EPS | $3.41 | $4.36 | $4.65 | $0.40 |
| Total assets (year end) | $2.23B | $1.98B | $1.65B | $1.32B |
| Cash and equivalents (year end) | $359.1M | $912.8M | $713.7M | $415.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Lantheus Holdings, Inc.
- Ticker
- LNTH (Nasdaq)
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Bedford, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1521036
- Former names
- Lantheus MI Holdings, Inc.
Frequently asked questions
What exchange is Lantheus Holdings, Inc. listed on?
Lantheus Holdings, Inc. trades on the Nasdaq under the ticker symbol LNTH.
What industry is Lantheus Holdings, Inc. in?
Lantheus Holdings, Inc. is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.
Where is Lantheus Holdings, Inc. headquartered?
Lantheus Holdings, Inc.'s business address on file with the SEC is in Bedford, MA.
When does Lantheus Holdings, Inc.'s fiscal year end?
Lantheus Holdings, Inc.'s fiscal year ends on December 31.
How much revenue did Lantheus Holdings, Inc. report?
Lantheus Holdings, Inc. reported $1.54B in revenue for calendar year 2025, according to its SEC filings.